Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION

Last updated on 2021-09-15 History
Report ID 144375
Drug Identification Number 02314932
Brand name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Common or Proper name Levofloxacin In 5% Dextrose Injection
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 24 x 100mL
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-31
Estimated end date
Actual end date 2021-09-14
Shortage status Resolved
Updated date 2021-09-15
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-09-15 English Compare
v7 2021-09-14 French Compare
v6 2021-09-14 English Compare
v5 2021-09-02 French Compare
v4 2021-09-02 English Compare
v3 2021-09-01 English Compare
v2 2021-08-20 French Compare
v1 2021-08-20 English Compare